COMMUNIQUÉS West-GlobeNewswire

Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025
23/10/2025
BEDFORD, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its third quarter 2025 [...]
SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
23/10/2025
TEL AVIV, Israel, Oct. 23, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat [...]
Rentschler Biopharma Inc. named Manufacturer of the Year for Central Massachusetts
23/10/2025
Company honored by state’s Legislative Manufacturing Caucus for outstanding leadership and contributions to the manufacturing sector State -of-the-art production line is bringing in new clients, new projects, new [...]
Instinct Science and Cornell University Hospital for Animals Modernize Veterinary Care with Instinct Treatment Plan
23/10/2025
PHILADELPHIA, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Instinct Science , a leading provider of clinical-grade software for veterinary hospitals, today announced that the Cornell University Hospital for Animals (CUHA) has [...]
Guerbet : Revenue at September 30, 2025. Return to growth in Q3 2025. Confirmation of all financial targets for 2025.
23/10/2025
Revenue at September 30, 2025 Return to growth in Q3 2025 9-month revenue: €586.5 million, down 2.8% at CER 1 and on a like-for-like basis 2 , largely due to the fall in activity in France An increase in Q3 of 2.6% at [...]
Guerbet : Chiffre d’affaires au 30 septembre 2025. Retour de la croissance au 3ème trimestre 2025. Confirmation de l’ensemble des objectifs financiers 2025.
23/10/2025
Chiffre d’affaires au 30 septembre 2025 Retour de la croissance au 3 ème trimestre 2025 Chiffre d’affaires à 9 mois : 586,5 M€, en retrait de 2,8% à TCC 1 et périmètre comparable 2 , largement dû à la baisse de l’ [...]
Avec Med4Cure, EUROAPI accélère l’innovation pharmaceutique au service de la souveraineté sanitaire
23/10/2025
Communiqué de presse L’événement inaugural de lancement du projet, organisé sur le site de Vertolaye, a réuni l’État, des élus et plusieurs partenaires pour accélérer l’innovation pharmaceutique en Europe Paris et [...]
With Med4Cure, EUROAPI accelerates pharmaceutical innovation at the service of health sovereignty
23/10/2025
Press Release The project launch event, held at the Vertolaye site, brought together State officials, elected representatives, and several project partners to accelerate pharmaceutical innovation in Europe Paris – [...]
eteraflex connects and CliniExperts Announce Global Alliance to Redefine Clinical Research and Regulatory Services Delivery
23/10/2025
Princeton, NJ, Oct. 23, 2025 (GLOBE NEWSWIRE) -- eteraflex connects and CliniExperts have announced a strategic partnership that unites their complementary expertise in clinical research, regulatory strategy, and [...]
ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
23/10/2025
-Two poster presentations showcase best- and first-in-class potential of ALX2004, a novel, antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors -Robust body of preclinical data supports [...]
Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference
23/10/2025
Preliminary efficacy data, combined with a tolerable safety profile, reinforce the potential of ZW191 in patients with advanced solid tumors, including ovarian, endometrial, and non-small cell lung cancer 64% overall [...]
Tango Therapeutics Announces $225 Million Financing
23/10/2025
Financing participants include Farallon Capital Management, TCGX, Balyasny Asset Management, Woodline Partners LP, Nextech, Invus, Adage Capital Management LP, Boxer Capital Management, Logos Capital, Nantahala Capital [...]
Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025
23/10/2025
TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 third quarter earnings conference call on Thursday, November 6, 2025 at 8:30 a.m. ET [...]
Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results
23/10/2025
MALVERN, Pa., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a [...]
Bionano Highlights Global Momentum Behind OGM at the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) Meeting
23/10/2025
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) participated in The American Society of Human Genetics (ASHG) conference from October 14–18, 2025 in Boston. The event highlighted the [...]
Moleculin Announces New Investigator-Initiated Study of Annamycin for Treating Pancreatic Cancer
23/10/2025
Atlantic Health, a leading provider of health care based in New Jersey, to conduct the investigator-initiated Phase 1B/2 study Preclinical studies indicate Annamycin targets key factors in pancreatic cancer HOUSTON, Oct [...]
Oncotelic to present at the 2025 San Antonio Breast Cancer Symposium (SABCS) Highlighting Sapu003 (Deciparticle™ Everolimus)
23/10/2025
Accepted Presentations Showcase First-in-Human Development, Manufacturing Innovation, and Predictive Biomarkers for Deciparticle™ Everolimus (Sapu003) AGOURA HILLS, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Oncotelic [...]
Beyond Air Schedules Second Fiscal Quarter 2026 Financial Results Conference Call and Webcast
23/10/2025
GARDEN CITY, N.Y., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Grace Therapeutics Secures Approximately $4.0 Million through Common Warrant Exercises Following Acceptance of New Drug Application for GTx-104 for formal FDA Review
23/10/2025
PRINCETON, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable [...]

Pages